COSVAC Study - Expression of Interest
The Omicron COVID-19 vaccine was manufactured in Adelaide and will be delivered to participants needle-free. This study will be undertaken at the Royal Adelaide Hospital (RAH). Your participation in this study will benefit development of vaccines against SARS-CoV-2 variants, such as the Omicron variant.
If you would like to express your interest to join the study, please fill your details below and a member of the PARC Clinical Research team from RAH will contact you for a telephone screening. Please contact PARC at (08) 7074 4404 or Health.PARCResearch@sa.gov.au should you have any further enquiries.
We are currently looking for:
- Healthy participants 18 years old and above
- Recovered from COVID-19 infection or received a COVID-19 vaccine boost more than four months ago.